West Pharmaceutical Services, I (WST) Financials

WST Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 3.8 billion 948.5 million
2023-09-30 3.8 billion 886.5 million
2023-06-30 3.7 billion 922.9 million
2023-03-31 3.7 billion 947.4 million

WST Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 130.4 million 1.4 million
2023-09-30 134.3 million 5.9 million
2023-06-30 93.8 million 7.5 million
2023-03-31 56.0 million 8.5 million

WST Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 137.0 million
2023-09-30 161.3 million
2023-06-30 155.1 million
2023-03-31 140.0 million

WST Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 853.9 million - 102.2 million
2023-09-30 898.6 million 152.1 million 99.5 million
2023-06-30 796.3 million 205.6 million 103.5 million
2023-03-31 886.3 million 206.1 million 106.1 million

WST Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 75.0 million
2023-09-30 75.3 million
2023-06-30 75.4 million
2023-03-31 75.7 million

WST Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 108.7 million 18.4 million 90.0 million -
2023-09-30 95.8 million 16.4 million 89.0 million -
2023-06-30 75.4 million 16.5 million 88.4 million -
2023-03-31 82.1 million 17.1 million 98.9 million -

WST Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 732.0 million 453.8 million
2023-09-30 747.4 million 459.1 million
2023-06-30 753.8 million 462.4 million
2023-03-31 716.6 million 445.3 million

WST

List: Champions

Price: $385.73

52 week price:
310.42
415.73

Dividend Yield: 0.00%

5-year range yield:
0.00%
0.57%

Forward Dividend Yield: 0.21%

Payout Ratio: 10.75%

Payout Ratio Range:
7.47%
95.16%

Dividend Per Share: 0.80 USD

Earnings Per Share: 7.89 USD

P/E Ratio: 53.53

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 800100

Ebitda: 85.9 million

Market Capitalization: 28.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 40

DGR3: 5.57%

DGR5: 5.92%

DGR10: 6.69%

DGR20: 6.45%

Links: